CytoReason vs Mydimed
CytoReason vs Mydimed, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Mydimed on 40/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 40/100
- domain rating: 40/100 against 1/100
- headcount: 116 against 8
- funding raised: $128M against $100K
Mydimed
Leads on none of the measures we hold for both companies.
At a glance
| Measure | CytoReason | Mydimed |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, Disease Management, HealthTech, MedTech |
| Sells toBusiness model | B2B | B2B, B2B2C |
| Offering | Software | Software |
| Founded | 2016 | 2016 |
| Headquarters | Tel Aviv, Israel | Not published |
| Status | Active | Inactive |
Size, funding and growth
| Measure | CytoReason | Mydimed |
|---|---|---|
| Employees | 116 | 8 |
| Headcount growthLast 12 months | +13.7% | Not published |
| Total funding | $128M | $100K |
| Latest round | Series B | Seed |
| LinkedIn followers | 12,830 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Mydimed |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 40/100 |
| Traction | 60/100 | 35/100 |
| Team | 70/100 | Not published |
| Search visibility | 30/100 | 4/100 |
| Quality | 78/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 1/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Mydimed |
|---|---|---|
| Analytics | Segment | Not detected |
CytoReason vs Mydimed: common questions
Which is better, CytoReason or Mydimed?
On our 0-100 score CytoReason rates higher (68/100 against 40/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do CytoReason and Mydimed compare on the numbers?
CytoReason leads on our overall score (68/100 against 40/100), domain rating (40/100 against 1/100), headcount (116 against 8), funding raised ($128M against $100K).
Read the full CytoReason review and pricing or the Mydimed review and pricing. You can also browse other CytoReason alternatives we track.